Saakshi Medtech Peer Comparison

NSE: SAAKSHI

₹296.10

₹14.10 (5.00%)

As on 28-Aug-2026IST

Market cap

₹582 Cr

Revenue (TTM)

₹92 Cr

P/E Ratio

47.4

P/B Ratio

4.2

Div. Yield

0 %

Edit

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Market cap (₹ Cr)	582	17,553	1,281	316	294
Revenue (₹ Cr)	92	1,997	314	153	183
Net Profit (₹ Cr)	4.71	307.01	24.51	4.34	12.72
Net Margin (%)	5.06	14.56	7.60	2.70	6.90
RoE (%)	4.92	10.63	13.94	2.29	10.39
Price to Earnings	47.39	55.71	22.98	72.90	26.98
Price-To-Book	4.17	5.52	6.05	1.72	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Operating Revenue	92.43	1,669.83	313.78	109.66	--
Total Income	93.00	1,758.96	322.58	122.37	--
Total Expenditure	82.12	1,214.12	239.29	117.47	--
EBITDA	10.31	455.71	74.49	-7.81	--
Depreciation	3.89	83.18	7.32	2.34	--
EBIT	6.42	372.53	67.17	-10.15	--
Interest	0.41	14.32	14.81	1.21	--
Other Income	0.57	89.13	8.80	12.71	--
Exceptional Items	--	--	-16.97	--	--
Profit before Tax	6.59	452.52	44.19	1.34	--
Provision for Tax	1.88	113.96	19.68	0.50	--
Profit after Tax	4.71	338.56	24.51	0.85	--

Liabilities (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Shareholder's Funds	98.04	2,765.66	189.95	194.29	--
Minority Interest	--	--	--	--	--
Non-Current Liabilities	14.44	56.40	85.42	-0.18	--
Current Liabilities	18.62	457.71	179.14	12.40	--
Total Liabilities	131.33	3,279.77	455.49	209.98	--

Assets (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Non-Current Assets	76.67	1,269.89	189.87	16.55	--
Current Assets	54.44	2,009.87	264.64	189.95	--
Total Assets	131.33	3,279.77	455.49	209.98	--
Total Debt*	17.82	177.65	166.29	2.37	--
Net Current Assets	35.81	1,552.17	85.50	177.55	--
Contingent Liabilities	5.29	77.12	--	0.02	--

Cashflow (₹ Cr)

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Cash From Operating Activities	3.02	233.05	-1.28	-19.08	--
Cash Flow from Investing Activities	-14.74	-1,187.18	-59.13	8.44	--
Cash from Financing Activities	-0.60	950.51	53.34	-0.17	--
Net Cash Inflow / Outflow	-12.32	-3.63	-7.07	-10.81	--

Ratios

Profitability Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
ROCE (%)	6.16	20.37	19.19	1.31	--
ROE (%)	4.92	16.01	13.94	0.44	--
ROA (%)	3.60	12.99	6.18	0.42	--
EBIT Margin (%)	11.77	32.63	26.54	4.46	--
Net Margin (%)	5.06	19.25	7.60	0.69	--
Cash Profit Margin (%)	7.98	25.15	10.15	2.61	--

Growth Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Revenue Growth (%)	-24.14	21.37	54.08	19.29	--
EBIT Growth (%)	-46.94	30.11	103.82	1,494.46	--
Net Profit Growth (%)	-58.34	31.09	13.27	147.16	--
EPS Growth (%)	-58.34	24.16	-18.34	147.16	--
Book Value Growth (%)	5.05	88.41	17.38	0.61	--

Valuation Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Price / Earnings	48.10	67.10	0.00	248.64	--
Price / Book Value	2.31	8.22	0.00	1.08	--
Dividend Yield (%)	0.00	0.16	--	0.00	--
EV/EBITDA	22.15	41.75	1.45	17.43	--
Market Cap (₹ Cr)	226.53	22,718.23	0.00	210.35	--

Solvency Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Debt to Equity	0.18	0.06	0.88	0.01	--
Short term debt to equity ratio	0.00	0.06	0.29	0.00	--
Current Ratio	2.92	4.39	1.48	15.32	--
Quick Ratio	1.83	3.77	0.97	12.10	--
Interest Coverage	17.26	32.59	3.98	2.11	--

Operating Efficiency Ratios

	Saakshi Medtech	Poly Medicure	Q-Line Biotech	Nureca	QMS Medical
Debtors to sales (%)	23.68	20.94	26.32	3.03	--
Asset Turnover	0.82	0.64	0.79	0.60	--
Receivable days	66.41	67.43	63.42	7.39	--
Inventory Days	71.27	55.13	113.68	105.87	--
Payable days	54.28	74.14	143.90	31.48	--
Cash Conversion Cycle	83.40	48.42	33.20	81.78	--

Annual
Quarterly